Evidence map›Paper›PMID 35909566›Full record

ArticleFrontiers in endocrinology2022

Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype.

Chisaka Kuehnemann, Kang-Quan Hu, Kayla Butera, Sandip K Patel, Joanna Bons, Birgit Schilling, Cristina Aguayo-Mazzucato, Christopher D Wiley

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Substrate Stiffness and Viscoelasticity Influence Fibroblast Senescence.Journal of biomedical materials research. Part A · 2026
    Article
  3. Review
  4. The Role of Renal Cell Senescence in Diabetic Kidney Disease: Mechanisms and Therapeutic Advances.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Chisaka KuehnemannJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States.
Kang-Quan HuJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States.
Kayla ButeraJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States.
Sandip K PatelBuck Institute for Research on Aging, Novato, CA, United States.
Joanna BonsBuck Institute for Research on Aging, Novato, CA, United States.
Birgit SchillingBuck Institute for Research on Aging, Novato, CA, United States.
Cristina Aguayo-MazzucatoJoslin Diabetes Center, Harvard Medical School, Boston, MA, United States.
Christopher D WileyJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States.
Buck Institute for Research on Aging · USTufts University · USJean Mayer Human Nutrition Research Center on Aging · USJoslin Diabetes Center · US

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for AgingU01AG060906 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI SCHILLING, BIRGIT · 2018 to 2022
$4.0M
Elucidating and targeting beta-cell senescence and its SASPR01DK132535 · NIDDK · JOSLIN DIABETES CENTER · PI Cristina Aguayo-Mazzucato · 2022 to 2026
$2.1M
Orbitrap Fusion Lumos ETD with FAIMS ProS10OD028654 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI SCHILLING, BIRGIT · 2020 to 2020
$1.1M
NIA NIH HHS P01 AG017242NIA NIH HHS U01 AG060906NIDDK NIH HHS R01 DK132535NIH HHS S10 OD028654
6 · The paper itself

Abstract

Cellular senescence is a stress or damage response by which a cell adopts of state of essentially permanent proliferative arrest, coupled to the secretion of a number of biologically active molecules. This senescence-associated secretory phenotype (SASP) underlies many of the degenerative and regenerative aspects of cellular senescence - including promoting wound healing and development, but also driving diabetes and multiple age-associated diseases. We find that nicotinamide phosphoribosyltransferase (NAMPT), which catalyzes the rate-limiting step in nicotinamide adenine dinucleotide (NAD) biosynthesis, is elevated in senescent cells without a commensurate increase in NAD levels. This elevation is distinct from the acute DNA damage response, in which NAD is depleted, and recovery of NAD by NAMPT elevation is AMPK-activated protein kinase (AMPK)-dependent. Instead, we find that senescent cells release extracellular NAMPT (eNAMPT) as part of the SASP. eNAMPT has been reported to be released as a catalytically active extracellular vesicle-contained dimer that promotes NAD increases in other cells and extends lifespan, and also as free monomer that acts as a damage-associated molecular pattern and promotes conditions such as diabetes and fibrosis. Senescent cells released eNAMPT as dimer, but surprisingly eNAMPT appeared in the soluble secretome while being depleted from exosomes. Finally, diabetic mice showed elevated levels of eNAMPT, and this was lowered by treatment with the senolytic drug, ABT-263. Together, these data reveal a new SASP factor with implications for NAD metabolism.

Indexed as

CytokinesDiabetes Mellitus, ExperimentalNicotinamide PhosphoribosyltransferaseSenescence-Associated Secretory PhenotypeAMP-Activated Protein KinasesAnimalsMiceNADAMP-Activated Protein KinasesCytokinesNADNicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, mouseagingcellular senescencediabeteseNAMPTNADNAMPTSASPsenescence

Identifiers

PMID35909566
PMCPMC9329521
OpenAlexW4285387093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.